Despite the above limitations, our study was carefully designed and developed following high methodological standards, and presents promising results, being the first meta-analysis to date specifically researching the prognostic implications of EGFR in oral cancer. The gene discussed is EGFR; the disease is lip and oral cavity carcinoma.